Pediatrician View en español, por el doctor Pablo Videla
El Dr. Pablo Videla habla sobre la Pediatrician View, la nueva tecnología desarrollada por FDNA. Este nuevo algoritmo permite a Read more
Webinar: Matching ultra-rare cases in the clinic
Check out now the recording of the webinar that took place on June 3rd, 2022 about matching ultra-rare cases in Read more
AI-Driven Facial Analysis Equals Better Healthcare for All
The world is bearing witness to a technological revolution that fundamentally changes how we do everything from creating music, Read more
Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Read more
Dr. John Carey: Delineating Genetic Syndromes and Next-Generation Phenotyping
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more
Dr. Karen Gripp: Face2Gene RESEARCH for Deep Phenotyping of Novel Syndromes
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more
Redefining Phenotyping for Clinical Advancements and Variant Prioritization
FDNA’s CEO, Dekel Gelbman, joined two distinguished members of the genetics community—Dr. John Carey (University of Utah) and Dr. Christine Read more
Happening at HIMMS: Precision Medicine Through Next-Generation Phenotyping—A Customer’s Journey
HIMSS Conference, Microsoft booth Thursday, March 7 3:40 PM PST Las Vegas, Nevada As over 40,000 health IT professionals, Read more
FDNA Announces Genomics Collaborative® at a Global Innovation Summit
English | Spanish In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced Read more
2017 Year in Review
At FDNA, we’re making precision medicine a reality by crowdsourcing knowledge and integrating next-generation phenotyping (NGP) technologies into every patient Read more
Drug Delivery Partnership: Precision Medicine Drives Discovery, Development and Commercialization in Pharma
In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only Read more
2017 Year of Discovery: An Overview
Boston-based health and tech start-up calls on patients and clinicians to share their stories to help make new discoveries needed Read more
Improving the Molecular Diagnostic Yield: Using Artificial Intelligence to Deliver Precision Phenomics
Genetic sequencing is becoming a more popular diagnostic tool; however, even with all the advancements, it only reaches a diagnosis Read more
FDNA Presents Rare Disease Technologies at the 2017 Precision Medicine Summit at Boston Children’s Hospital
The Division of Genetics and Genomics Department of Medicine at Boston Children’s Hospital will present their exciting new Fall Precision Read more
Facial Analysis Discoveries for CHARGE Syndrome in the Year of Discovery
The performance of FDNA’s facial analysis technology, Face2Gene, was recently put up to the challenge of recognizing facial features of Read more
Facial Analysis Discoveries for Sanfilippo Syndrome B (MPS IIIB)
In May, FDNA reached out to clinicians and patients globally as part of the Year of Discovery to collect and Read more
Age-specific Facial Analysis Discoveries for Overgrowth Syndromes in the Year of Discovery
In April 2017, FDNA analyzed patient data from syndromes categorized as Overgrowth Syndromes as part of the Year of Discovery, Read more
New Facial Analysis Discoveries for RASopathy Syndromes in the Year of Discovery
In March, FDNA reached out to clinicians and patients globally as part of the Year of Discovery to collect Read more
From Genomics to Groceries, the Future Belongs to Those That Use A.I.
published as part of Access A.I.’s publication: “AI and Business: a Practical Guide.“ Our world is filled with data. Data Read more
How data warehouses can speed identification of rare diseases
Dekel Gelbman, CEO of FDNA, was featured in Health Data Management discussing the value for hospitals of using clinical data Read more